SEC Comment Letter for Imunon, Inc. (IMNN) (CIK 0000749647) (IMNN) — Apr 6, 2017

Imunon, Inc. (IMNN) (CIK 0000749647)
Date: April 6, 2017 · CIK: 0000749647 · Accession: 0000000000-17-011769

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

April 5, 2017

Author

Jeffrey Church

Form

UPLOAD

Company

Imunon, Inc. (IMNN) (CIK 0000749647)

Letter

April 5, 2017 Jeffrey Church Chief Financial Officer Celsion Corporation 997 Lenox Drive, Suite 100 Lawrenceville, NJ 08648 Celsion Corporation Preliminary Proxy Statement on Schedule 14A Filed March 20, 2017 File No. 001-15911Re: Dear Mr. Church: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence by the staff. Division of Corporation Finance Office of Healthcare and Insurance cc: Sam Zucker

Show Raw Text

April 5, 2017
Jeffrey  Church
Chief Financial Officer
Celsion Corporation
997 Lenox Drive, Suite 100
Lawrenceville, NJ 08648
Celsion Corporation
Preliminary Proxy Statement on Schedule 14A
Filed March 20, 2017
File No. 001-15911Re:
Dear Mr. Church:
        We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence by the staff.
Division of Corporation Finance
Office of Healthcare and
Insurance
cc: Sam Zucker

SecProbe.io